Abstract
Objective: We describe a psoriasis patient who let his dog lick his psoriasis lesions, which resulted in nonadherence to prescribed topical calcipotriol/betamethasone dipropiontae (Cal/BD) cutaneous foam. Methods: The patient’s adherence to (Cal/BD) cutaneous foam was objectively monitored by a chip in the medication dispenser and the patient was subsequently visited at his home to observe the dog’s licking process and obtain clinical photos. Conclusion: Topical antipsoriatic drugs containing corticosteroid/calcipotriol preparations are first-line treatment for mild-to-moderate psoriasis, but adherence rates to topical antipsoriatic drugs are low and a barrier for full efficacy of the treatment. Physicians should be aware that a dog licking off psoriasis scales can lead to nonadherence to topical treatment as well as expose the dog owners and their dogs to a risk of adverse events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
